Table 1

Clinical categories of patients with an initial clinical diagnosis of TTP, 1989-2008

Clinical categoryAll patients, 1989-2008 (N = 376)
Patients with ADAMTS13 activity measurements at the time of their initial diagnosis with TTP, 1995-2008
Total (n = 261)
ADAMTS13 activity
10% or more (n = 201)
< 10% (n = 60)
< 5%* (n = 49)
No. of patients (no. of patients who survived)
Stem cell transplantation 23 (6) 10 (1) 9 (1) 1 (0) 
Pregnant/postpartum 27 (25) 15 (14) 12 (11) 3 (3) 2 (2) 
Drug association 49 (41) 35 (32) 35 (32) 
Bloody diarrhea 28 (21) 22 (17) 20 (15) 2 (2) 2 (2) 
Additional or alternative disorder      
    Autoimmune disorder 40 (27) 31 (21) 28 (18) 3 (3) 3 (3) 
    Systemic infection 30 (8) 22 (7) 18 (5) 4 (2) 1 (1) 
    Systemic malignancy 13 (2) 10 (2) 9 (2) 1 (0) 
    Malignant hypertension 6 (6) 6 (6) 6 (6) 
    Multiorgan failure 11 (3) 11 (3) 11 (3) 
    Congenital hemolytic anemia 1 (1) 1 (1) 1 (1) 
Idiopathic 148 (118) 98 (79) 52 (42) 46 (37) 41 (33) 
Total 376 (258) 261 (178) 201 (136) 60 (47) 49* (41) 
Clinical categoryAll patients, 1989-2008 (N = 376)
Patients with ADAMTS13 activity measurements at the time of their initial diagnosis with TTP, 1995-2008
Total (n = 261)
ADAMTS13 activity
10% or more (n = 201)
< 10% (n = 60)
< 5%* (n = 49)
No. of patients (no. of patients who survived)
Stem cell transplantation 23 (6) 10 (1) 9 (1) 1 (0) 
Pregnant/postpartum 27 (25) 15 (14) 12 (11) 3 (3) 2 (2) 
Drug association 49 (41) 35 (32) 35 (32) 
Bloody diarrhea 28 (21) 22 (17) 20 (15) 2 (2) 2 (2) 
Additional or alternative disorder      
    Autoimmune disorder 40 (27) 31 (21) 28 (18) 3 (3) 3 (3) 
    Systemic infection 30 (8) 22 (7) 18 (5) 4 (2) 1 (1) 
    Systemic malignancy 13 (2) 10 (2) 9 (2) 1 (0) 
    Malignant hypertension 6 (6) 6 (6) 6 (6) 
    Multiorgan failure 11 (3) 11 (3) 11 (3) 
    Congenital hemolytic anemia 1 (1) 1 (1) 1 (1) 
Idiopathic 148 (118) 98 (79) 52 (42) 46 (37) 41 (33) 
Total 376 (258) 261 (178) 201 (136) 60 (47) 49* (41) 

The 376 patients who were enrolled in the Registry for their first episode of clinically diagnosed TTP are presented according to their clinical categories, with the number of surviving patients in parentheses. In addition, the 261 patients who had ADAMTS13 activity measured at the time of their initial diagnosis are presented separately, including the subgroups of 201 patients whose ADAMTS13 activity was ≥ 10%, the 60 patients whose ADAMTS13 activity was < 10%, and the 49 patients whose ADAMTS13 activity was < 5%.

*

Patients with < 5% activity (n = 49) are a subset of patients with < 10% activity (n = 60).

Close Modal

or Create an Account

Close Modal
Close Modal